1. Nenghui Science and Technology: won the bid for 107.3 million yuan of photovoltaic project EPC general contract

Nenghui Science and Technology announcement, won the bid Guangzhou Development Lechang to 60MW photovoltaic project EPC general contract, winning the bid price of 107.3 million yuan.

　　two。 Lu Kang Medicine: CMS203 tablets are approved in clinical trials

Lu Kang Medicine announced that CMS203 tablets were approved in clinical trials for the treatment of male erectile dysfunction (ED).

　3. China West Power: the State Council agrees to the reorganization and integration of some subsidiary enterprises of China West Power Group and State Grid Co., Ltd.

China West Power announced that it had received notification from its controlling shareholder, China West Power Group Co., Ltd., which was studied by the State-owned assets Supervision and Administration Commission of the State Council and submitted to the State Council for approval. It is agreed that China West Power Group and some subsidiary enterprises of State Grid Co. After this reorganization and integration, the company's controlling shareholders and actual controllers have not changed.

　　4. China Coal Energy: commercial coal sales of 24.4 million tons in August increased by 3.6% over the same period last year.

China Coal Energy released data on major production and operation in August 2021. In the coal business, commercial coal output was 8.82 million tons, down 10% from the same period last year; commodity coal sales were 24.4 million tons, up 3.6% from the same period last year; of which 8.97 million tons were self-produced commercial coal, down 8.6% from the same period last year.

　　5. Jinzhi Technology: plans to set up a carbon neutralization fund with Haitong Jihe

Jinzhi Science and Technology announcement, and Haitong Jihe signed a "letter of intent to jointly initiate the establishment of a carbon neutralization fund", the size of the fund is 1 billion yuan, the first phase scale is 500 million yuan.

　6. Xiamen Tungsten Xineng: signed a strategic cooperation agreement with Zhongwei to purchase 15000-35000 tons / year of ternary precursors

Xiamen Tungsten Xinneng announced that the company and Zhongwei signed the Strategic Cooperation Framework Agreement. From the date of the signing of the agreement to December 31, 2023, the two sides estimate that the supply and demand of cobalt tetroxide products is about 20000-25000 tons / year. The supply and demand of ternary precursor products is about 15000-35000 tons / year, the above quantity is the reasonable forecast made by both parties according to the current market situation, if the follow-up industry policy and market supply and demand situation changes, the corresponding quantity will be adjusted, the company does not make procurement guarantee, the specific purchase quantity and purchase price shall be subject to the purchase order signed by both parties.

　　7. Anada: the domestic sales price of titanium dioxide has been increased by 1000 yuan / ton.

Anada announcement, according to the recent domestic and international market demand for titanium dioxide and the rise in raw material prices, the company decided to raise the sales prices of its main products from September 15, 2021. Rutile titanium dioxide and anatase titanium dioxide domestic sales prices are increased by 1000 yuan / ton, export prices are increased by 150 U.S. dollars / ton.

　　8. Tianyao Co., Ltd.: valine API products get CEP certificate

According to the announcement of Tianyao Co., Ltd., recently, the company received the European Pharmacopoeia applicability Certification Certificate (CEP Certificate) issued by the European Drug quality Administration ("EDQM") for valine raw materials, which is the first time that the company has obtained the CEP certificate for its amino acid products. Valine is one of the eight essential amino acids and sugar-producing amino acids for the human body. it works with other two high concentrations of amino acids (isoleucine and leucine) to promote normal growth, repair tissue, regulate blood sugar, and provide the necessary energy.

　　9. Tianji shares: estimated net profit of 440 million-460 million yuan in the first three quarters. Production and marketing of lithium hexafluorophosphate products are booming.

Tianji shares announced that it is expected to make a net profit of 440 million-460 million yuan in the first three quarters, compared with a loss of 43.75 million yuan in the same period last year. In the first three quarters, the company's production and sales of lithium hexafluorophosphate products are booming, coupled with the increase in sales prices, lithium hexafluorophosphate performance increased significantly compared with the same period

　　10. Yintai Gold: acquire 60% stake in Huasheng Gold Mine for 1.037 billion yuan

Yintai Gold announcement, the acquisition of 60% of Mangshi Huasheng Gold Development Co., Ltd., the transaction price of 1.037 billion yuan, so far, the company has completed the above equity transfer change registration procedures. The main business of Huasheng Gold Mine is synergy gold mining and smelting, and the core asset is the mining right of Mangshi Gold Mine. It has obtained a mining license. The current production scale is 100000 tons / year, and it is applying for a change to 1.2 million tons / year. As of December 31, 2020, Mangshi Gold Mine has 23.225 million tons of gold resources, 70.67 tons of gold and metal, and the average grade of Au is 3.04g / ton.

　　11. One machine in Inner Mongolia: received 416 million yuan of railway freight car purchase contract

Inner Mongolia first engine announcement, received the "X70 Railway Freight car Purchasing Project contract" signed between the wholly-owned subsidiary Beichuang Company and China State Railway Group Co., Ltd. China State Railway Group Co., Ltd. purchased 1100 X70 container special flat cars from Beichuang Company, with a total contract amount of 416 million yuan.

　　twelve。 Dirui Medical: 10 medical device products have obtained CE certification

Dirui Medical announcement, the company's 10 medical device products recently obtained the CE certification.